Luisa Beltran

Swan joins General Atlantic as Operating Partner

General Atlantic said Tuesday that Robert Swan has joined as an Operating Partner. He will be part of the firm's Resources Group. Swan is the former CFO of eBay Inc.

Monument Group adds three to Hong Kong office

Monument Group said Tuesday it hired three professionals in its Hong Kong office. They include: Albert Jun, Director; Sabrina Meng, Senior Associate; and, Kris Ho, Operations Manager. The three join Niklas Amundsson, a Managing Director, who began at Monument Group in January. Amundsson previously spent seven years at MVision.

Cinven to sell Amdipharm Mercury for $3.5 billion

Concordia Healthcare Corp. said Tuesday it has agreed to buy Amdipharm Mercury Ltd. for about $3.5 billion. The seller is Cinven. The $3.5 billion will consist of $1.2 billion cash, $700 million stock, the assumption of $1.4 billion in debt and a maximum performance-based cash earn-out of $220 million payable in fourth quarter 2016. Goldman, Sachs & Co., Credit Suisse, RBC Capital Markets and Jefferies are providing financing. London-based Amdipharm Mercury is pharmaceutical company.

Selecta Biosciences raises $38 mln

Selecta Biosciences Inc. said Tuesday it raised $38 million in a Series E financing round. OrbiMed is the largest investor in the round which includes new investors, Sanofi-Genzyme BioVentures, Ridgeback Capital Management, Osage University Partners, AJU IB Investment and Sphera Global Health Care Fund. All of Selecta’s existing investors also participated. Watertown, Massachusetts-based Selecta is clinical stage biotechnology company.

SetPoint Medical raises another $15 mln

SetPoint Medical said Tuesday it raised an additional $15 million in an extension to its Series C equity financing. SetPoint did not name its new, strategic investor, while three existing strategic investors from the company’s existing syndicate participated in the extension. Action Potential Venture Capital also increased its position. Valencia, California-based SetPoint, a biomedical technology company that is developing a bioelectronic therapy for inflammatory diseases, has raised a total of $43 million in the round.

Cambridge Capital blank check company merges with Ability Computers

Ability Computers & Software Industries Ltd. is merging with Cambridge Capital Acquisition Corp. in a deal valued at $192 million. Tel Aviv, Israel-based Ability provides communications intelligence solutions used by government agencies, military forces and law enforcement. Cambridge Capital Acquisition Corp. is a blank check company backed by Cambridge Capital, a private equity firm from West Palm Beach, Florida.

PE HUB First Read

To start your morning, we have news that Amazon plans to sell a $50 tablet in time for the holidays, BlaBlaCar is raising $160 million at a $1.2 billion valuation and the dentist who killed Cecil the Lion plans to go back to work.

Forbion Capital invests in Sanifit's $41 mln round

Sanifit raised 36.6 million Euros (US$41 million) in a Series C round of financing. Forbion Capital Partners took part in the round as well as Ysios Capital, Lundbeckfond Ventures, Gilde Healthcare, Edmond de Rothschild Investment Partners, “la Caixa” and Baxter Healthcare. Existing shareholders also supported the series C round. Sanifit is a Spanish clinical-stage biopharmaceutical company.

Paine & Partners ends deal to sell Icicle to Convergence, Dominion

Paine & Partners LLC said Friday that it has called off its agreement to sell Icicle Holdings to Convergence Holdings Inc. and Dominion Catchers LLC. Paine & Partners did not disclose a reason why it terminated the deal. The private equity firm said it plans to reinitiate a sales process for Icicle once the 2015 salmon season has ended. In June, Paine & Partners agreed to sell Icicle to Convergence and Dominion. Seattle-based Icicle is a seafood company.

Davison named CEO of Pillarstone

KKR Credit said Monday that John Davison was named CEO of Pillarstone. KKR Credit recently launched Pillarstone to support banks in managing their exposures to non-core and under-performing assets including corporate loans, real estate and shipping. Davison is the former Global Head of Strategic Investments at Royal Bank of Scotland. He is also a co-investor in Pillarstone.